Medical Crossfire®: Individualizing Treatment in CRPC Based on Patient- and Disease-Specific Factors | Live CME

Look no further. PER®’s insightful complimentary satellite will feature renowned experts in urology and prostate cancer evaluating the efficacy, safety, and sequencing of therapies used for the management of CRPC. Register now: https://t.co/cb3OJjh22A #ProstateCancer #GOTOPER https://t.co/jpPOqjnLdr